Latest Articles
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus - Investing.com India
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus Investing.com India
Published: March 19, 2026, 9 p.m.
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus - Investing.com
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus Investing.com
Published: March 19, 2026, 8:25 p.m.
CORRECTION: Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods - The Manila Times
CORRECTION: Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods The Manila Times
Published: March 19, 2026, 2:19 p.m.
CORRECTION: Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods - Yahoo Finance
CORRECTION: Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods Yahoo Finance
Published: March 19, 2026, 2:11 p.m.
Endometrial receptivity, immune signals and timing: The invisible barriers to conception that may be labe - The Times of India
Endometrial receptivity, immune signals and timing: The invisible barriers to conception that may be labe The Times of India
Published: March 19, 2026, 8:20 a.m.
Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+ - openPR.com
Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+ openPR.com
Published: March 17, 2026, 11:40 p.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - Cure Today
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models Cure Today
Published: March 17, 2026, 5:11 p.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - CUREtoday.com
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models CUREtoday.com
Published: March 17, 2026, 4:12 p.m.
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors - Technology Networks
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors Technology Networks
Published: March 17, 2026, 4:04 p.m.
UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer - Sierra Sun Times
UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer Sierra Sun Times
Published: March 17, 2026, 2:29 p.m.
Link copied to clipboard!